Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

27 Dec 2017 16:35

RNS Number : 3909A
Vernalis PLC
27 December 2017
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PMEPGGAWPUPMGQM
Date   Source Headline
25th Nov 201410:13 amRNSHolding(s) in Company
18th Nov 20147:00 amRNSChange of Year End & Commercial Business Update
6th Nov 20147:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
5th Nov 201412:15 pmRNSHolding(s) in Company
5th Nov 201412:07 pmRNSHolding(s) in Company
3rd Nov 20145:06 pmRNSHolding(s) in Company
31st Oct 20145:17 pmRNSHolding(s) in Company
31st Oct 20147:00 amRNSTotal Voting Rights
27th Oct 20147:00 amRNSCTI becomes worldwide licensee for tosedostat
14th Oct 20143:55 pmRNSTransactions of Directors
10th Oct 20147:00 amRNSVernalis opens US office and strengthens US team
9th Oct 20147:00 amRNSVernalis licenses V2006 to RedoxTherapies Inc
15th Sep 20147:00 amRNSFDA accepts TuzistraTM XR NDA for full review
5th Sep 201410:30 amRNSHolding(s) in Company
29th Aug 20144:00 pmRNSTotal Voting Rights
14th Aug 201410:59 amRNSHolding(s) in Company
5th Aug 20147:00 amRNSInterim results for six months ended 30 June 2014
4th Aug 20147:00 amRNSVernalis & Servier achieve 2 Research Milestones
31st Jul 20147:00 amRNSTotal Voting Rights
22nd Jul 20147:00 amRNS3rd Product in Cough Cold Pipeline Achieves POC
17th Jul 20147:00 amRNSNotice of Results for 6 Months Ended 30 June 2014
30th Jun 20147:15 amRNSTotal Voting Rights
30th Jun 20147:00 amRNSSubmission of TuzistraTM XR (CCP-01) NDA to FDA
19th Jun 20147:00 amRNSVernalis & Servier Achieve Research Milestone
30th May 20143:30 pmRNSTotal Voting Rights
23rd May 201411:48 amRNSResult of AGM
16th May 201410:47 amRNSHolding(s) in Company
6th May 20146:16 pmRNSBLOCK LISTING SIX MONTHLY RETURN
6th May 20144:31 pmRNSHolding(s) in Company
1st May 20143:15 pmRNSHolding(s) in Company
30th Apr 20149:00 amRNSTotal Voting Rights
29th Apr 20147:00 amRNS2nd Product in Cough Cold Pipeline Achieves POC
24th Apr 20147:00 amRNSPromising Results of Ph Ib/II POC Study in ADHD
22nd Apr 20147:01 amRNSVernalis Research wins Queens Award for Enterprise
15th Apr 20147:00 amRNSNotice of Annual Report and AGM
7th Apr 20145:41 pmRNSTransactions of Directors and Applicable Employee
1st Apr 20147:00 amRNSAnnouncement of Results for year ended 31 Dec 2013
31st Mar 20144:23 pmRNSTotal Voting Rights
27th Mar 20147:00 amRNSVernalis and Asahi Kasei Pharma Achieve Milestone
6th Mar 20147:00 amRNSAppointment of Joint Broker
5th Mar 20143:00 pmRNSNotice of Results
24th Feb 20147:00 amRNSVernalis Announces Successful Completion of Study
7th Feb 20147:00 amRNSAppointment of Nominated Adviser and Broker
29th Nov 20137:00 amRNSTotal Voting Rights
25th Nov 20137:00 amRNSVernalis Announces Successful Study with CCP-01
21st Nov 20135:05 pmRNSHolding(s) in Company
6th Nov 20137:00 amRNSBlock Listing Application
1st Oct 20134:40 pmRNSSecond Price Monitoring Extn
1st Oct 20134:35 pmRNSPrice Monitoring Extension
1st Oct 20137:00 amRNSVernalis enters into research collaboration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.